The company's CEO will defend her company's increase in EpiPen pricing. — -- Mylan Pharmaceuticals CEO Heather Bresch is expected to defend her company’s increase in EpiPen pricing when she ...
Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its life-saving EpiPens and the profits for a company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback